Exercise may keep frail pancreatic cancer patients stronger during chemo

NCT ID NCT07647250

Recruiting now Symptom relief Sponsor: University of Illinois at Chicago Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tests whether a 36-session targeted exercise program can help frail pancreatic cancer patients stay stronger and complete their chemotherapy with fewer problems. Researchers will enroll 25 patients who are frail or pre-frail and receiving chemotherapy before surgery. The main goal is to see if the program is practical and safe, with early signs of whether it improves strength and daily function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: targeted physical exercise program
What this could lead to: If it works, this could show that regular exercise helps frail pancreatic cancer patients maintain strength and complete chemotherapy with fewer interruptions.
What could go wrong: This is a very small pilot study with only 25 people, so results may not apply to everyone. The main goal is to see if the program is feasible, not to prove it works.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PANCREATIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

malignant pancreatic neoplasm Motor Activity

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

PHYSICAL EXERCISE PHYSIOLOGICAL REACTIVITY TO CUES

Contacts and locations

Locations

University of Illinois Clinical Cancer Center
RECRUITING

Chicago, Illinois, 60612, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.